Loading…
View analytic
avatar for Sandra Kweder

Sandra Kweder

FDA
Deputy Director, Liaison to the EMA, Office of International Programs, OC
Dr. Sandra L. Kweder was named Deputy Director of the Europe Office in the FDA Office of International Programs (OIP) in March 2016. Dr. Kweder previously served for more than a decade as Deputy Director, Office of New Drugs (OND) in FDA’s Center for Drug Evaluation & Research (CDER), where she actively led numerous initiatives including improvements in the drug review process; modernizing nonprescription drug review; building a systematic drug shortage prevention and management program; patient-focused drug development and clinical outcomes assessments; and the growth and development of pediatric and maternal health as standard aspects of drug development.